|
DCTN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.760600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.933400E-01 |
| Normal-vs-Stage2 |
3.027400E-01 |
| Normal-vs-Stage3 |
2.195800E-02 |
| Normal-vs-Stage4 |
9.671800E-01 |
| Stage1-vs-Stage2 |
3.509800E-01 |
| Stage1-vs-Stage3 |
7.280100E-03 |
| Stage1-vs-Stage4 |
6.568600E-01 |
| Stage2-vs-Stage3 |
3.596000E-01 |
| Stage2-vs-Stage4 |
3.197400E-01 |
| Stage3-vs-Stage4 |
2.829800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.801370E-01 |
| Normal-vs-AfricanAmerican |
8.301200E-01 |
| Normal-vs-Asian |
6.352200E-02 |
| Caucasian-vs-AfricanAmerican |
3.539400E-01 |
| Caucasian-vs-Asian |
7.017900E-03 |
| AfricanAmerican-vs-Asian |
4.344100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.708190E-01 |
| Normal-vs-Female |
6.833600E-01 |
| Male-vs-Female |
1.620970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.995600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.142000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.059600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.972400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.577200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.254200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.065600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.667200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.270800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.683600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.313800E-01 |
| Normal-vs-Grade 2 |
5.729400E-01 |
| Normal-vs-Grade 3 |
2.015200E-01 |
| Normal-vs-Grade 4 |
8.429900E-02 |
| Grade 1-vs-Grade 2 |
4.913600E-01 |
| Grade 1-vs-Grade 3 |
2.885200E-01 |
| Grade 1-vs-Grade 4 |
1.645800E-01 |
| Grade 2-vs-Grade 3 |
2.826200E-01 |
| Grade 2-vs-Grade 4 |
7.950100E-02 |
| Grade 3-vs-Grade 4 |
3.292600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.129600E-01 |
| Normal-vs-ccB subtype |
2.945600E-01 |
| ccA subtype-vs-ccB subtype |
6.358800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.568600E-01 |
| Normal-vs-N1 |
3.620000E-01 |
| N0-vs-N1 |
1.863580E-01 |
|
|
